Shell Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Shell Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,082	Closed	-$46K	–	1352
2022 Q4	$46K	Buy	+3,082	New	+$42.7K	﹤0.01%	1272

Shell Asset Management's AVEO Position: Q1 2023 in Review

Shell Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 3,082 shares — an estimated $46K sold.

Shell Asset Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $46K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Shell Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Shell Asset Management sold 3,082 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $46K.
Shell Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Shell Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $46K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Shell Asset Management's 13F filing for Q1 2023, filed 15 May 2023.